» Articles » PMID: 8952541

Allelic Deletions of the VHL Gene Detected in Multiple Microscopic Clear Cell Renal Lesions in Von Hippel-Lindau Disease Patients

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1996 Dec 1
PMID 8952541
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with von Hippel-Lindau (VHL) disease develop a spectrum of bilateral clear-cell renal lesions including cysts and renal cell carcinomas (RCCs). VHL gene deletions have been previously reported in VHL-associated macroscopic RCC. Although histological analysis suggests that microscopic cystic lesions in the VHL patients may represent precursors of the RCC, there is at present no direct molecular evidence of their relationship. To investigate the relationship between cystic lesions and RCC, 26 microdissected archival renal lesions from two VHL disease patients were studied for loss of heterozygosity at the VHL gene locus using polymerase chain reaction single-strand conformation polymorphism analysis. The renal lesions included 2 benign cysts, 5 atypical cysts, 5 microscopic RCCs in situ, 5 cysts lined by a single layer of cells, in which RCCs in situ were developing, and 2 microscopic and 7 macroscopic RCCs. Except for a single benign cyst, 25 of 26 renal lesions showed nonrandom allelic loss of the VHL gene. In either of the 2 patients, the same VHL allele was deleted in all of the lesions tested, indicating loss of the wild-type allele and retention of the inherited, mutated VHL allele. The results suggest that all clear-cell lesions in the VHL kidney represent neoplasms and that the loss of the VHL gene occurs early in their development. Atypical and benign cysts most likely represent the initial phenotype in malignant transformation to the RCC.

Citing Articles

Molecular chaperones: Guardians of tumor suppressor stability and function.

Heritz J, Backe S, Mollapour M Oncotarget. 2024; 15:679-696.

PMID: 39352796 PMC: 11444336. DOI: 10.18632/oncotarget.28653.


von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.

Shirole N, Kaelin Jr W Hematol Oncol Clin North Am. 2023; 37(5):809-825.

PMID: 37270382 PMC: 11315268. DOI: 10.1016/j.hoc.2023.04.011.


The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma.

Oxburgh L Cancers (Basel). 2022; 14(17).

PMID: 36077607 PMC: 9454539. DOI: 10.3390/cancers14174072.


Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.

Wang J, Chang H, Su M, Qiao Y, Sun H, Zhao Y Int J Mol Sci. 2022; 23(9).

PMID: 35562974 PMC: 9102202. DOI: 10.3390/ijms23094583.


Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.

Jonasch E, Walker C, Rathmell W Nat Rev Nephrol. 2020; 17(4):245-261.

PMID: 33144689 PMC: 8172121. DOI: 10.1038/s41581-020-00359-2.


References
1.
Knudson Jr A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68(4):820-3. PMC: 389051. DOI: 10.1073/pnas.68.4.820. View

2.
Shinohara N, Nonomura K, Harabayashi T, Togashi M, Nagamori S, Koyanagi T . Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. J Urol. 1995; 154(6):2016-9. View

3.
Zbar B, Brauch H, Talmadge C, Linehan M . Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 1987; 327(6124):721-4. DOI: 10.1038/327721a0. View

4.
Solomon D, Schwartz A . Renal pathology in von Hippel-Lindau disease. Hum Pathol. 1988; 19(9):1072-9. DOI: 10.1016/s0046-8177(88)80089-3. View

5.
Lamiell J, Salazar F, HSIA Y . von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore). 1989; 68(1):1-29. DOI: 10.1097/00005792-198901000-00001. View